EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Large‐Scale Serological Survey in Pets From October 2020 Through June 2021 in France Shows Significantly Higher Exposure to SARS ‐ CoV ‐2 in Cats Compared to Dogs

Matthieu Fritz iD, Eric Elguero, Pierre Becquart iD, Daphné De Riols de Fonclare iD, Déborah Garcia, Stephanie Beurlet iD, Solène Denolly iD, Bertrand Boson iD, Serge G Rosolen iD, François-Loïc Cosset iD, Alexandra Briend-Marchal, Vincent Legros iD und 1 weitere

Zoonoses and Public Health · 2025

DOI: 10.1111/zph.13198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Zoonoses and Public Health, 2025. Verfasst von Matthieu Fritz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Maladies Infectieuses et Vecteurs, Ecologie, Génétique, Evolution et Contrôle (MIVEGEC), Univ. Montpellier, IRD, CNRS, Montpellier, France. Hauptthemen laut MEDLINE: Dog Diseases, Cat Diseases, COVID-19, SARS-CoV-2. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has the potential to infect various animals, including domestic pets like dogs and cats. Many studies have documented infection in companion animals by molecular and serological methods. However, only a few have compared seroprevalence in cats and dogs from the general population, and these studies were limited by small sample sizes and collections over short periods. Our aim was to obtain a more accurate evaluation of seroprevalence in companion animals in France and to determine whether cats and dogs differ in their exposure to SARS‐CoV‐2.

Methods

We conducted an extensive serological survey of SARS‐CoV‐2, collecting blood samples from 2036 cats and 3577 dogs during routine veterinary medical examinations across different regions of metropolitan France from October 2020 to June 2021. This period encompassed the peaks and onset of two waves, as well as the emergence of the first variants. A microsphere immunoassay targeting the receptor‐binding domain and trimeric spike protein was used to detect anti‐SARS‐CoV‐2 antibodies. A subset of 308 seropositive samples was tested for the presence of neutralising antibodies.

Results

We determined an overall seroprevalence of anti‐SARS‐CoV‐2 antibodies of 7.1% (95% confidence interval [CI]: 6.4%–7.8%) among the sampled pets. Cats exhibited a significantly higher seroprevalence (9.3%; 95% CI: 8.1%–10.1%) compared to dogs (5.9%; 95% CI: 5.2%–6.8%). Among the subset of seropositive samples, 81 (26.3%; 95% CI: 21.5%–31.6%) displayed neutralizing antibodies. Furthermore, seroprevalence in both species was lower in older animals and was not associated with sex. Finally, unlike cats, seroprevalence in dogs was found to be correlated with the date of sampling.

Conclusions

The large sample size enhances the reliability and statistical robustness of our estimates regarding pet exposure to SARS‐CoV‐2. This study on SARS‐CoV‐2 reaffirms the crucial importance of adopting a One Health approach incorporating domestic animals when managing an epidemic caused by a zoonotic virus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesCat DiseasesCOVID-19SARS-CoV-2PetsAnimalsCatsDogsFranceSeroepidemiologic StudiesAntibodies, ViralFemaleMale

Stichwörter der Autor:innen

SARS‐CoV‐2microsphere immunoassayneutralisation assayone healthpetsserology

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • Maladies Infectieuses et Vecteurs, Ecologie, Génétique, Evolution et Contrôle (MIVEGEC), Univ. Montpellier, IRD, CNRS, Montpellier, France.
  • Laboratoire de Biologie vétérinaire VEBIO, Arcueil, France.
  • CIRI - Centre International de Recherche en Infectiologie, Team EVIR, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR5308, ENS Lyon, Lyon, France.
  • Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
  • Clinique vétérinaire Voltaire, Asnières, France.
  • Université de Lyon, VetAgro Sup, Campus vétérinaire de Lyon, Marcy-l'Etoile, Lyon, France.

ORCID-Profile: Matthieu Fritz, Pierre Becquart, Daphné De Riols de Fonclare, Stephanie Beurlet, Solène Denolly, Bertrand Boson, Serge G Rosolen, François-Loïc Cosset, Vincent Legros, Eric M Leroy

Zitieren

APA

Fritz, M., Elguero, E., Becquart, P., De Riols de Fonclare, D., Garcia, D., Beurlet, S., Denolly, S., Boson, B., Rosolen, S. G., Cosset, F. L., Briend-Marchal, A., Legros, V., & Leroy, E. M. (2025). A Large‐Scale Serological Survey in Pets From October 2020 Through June 2021 in France Shows Significantly Higher Exposure to SARS ‐ CoV ‐2 in Cats Compared to Dogs. Zoonoses and Public Health. https://doi.org/10.1111/zph.13198

Vancouver

Fritz M, Elguero E, Becquart P, De Riols de Fonclare D, Garcia D, Beurlet S, et al. A Large‐Scale Serological Survey in Pets From October 2020 Through June 2021 in France Shows Significantly Higher Exposure to SARS ‐ CoV ‐2 in Cats Compared to Dogs. Zoonoses and Public Health. 2025. doi:10.1111/zph.13198

BibTeX
@article{Fritz2025,
  author = {Fritz, Matthieu and Elguero, Eric and Becquart, Pierre and De Riols de Fonclare, Daphné and Garcia, Déborah and Beurlet, Stephanie and Denolly, Solène and Boson, Bertrand and Rosolen, Serge G and Cosset, François-Loïc and Briend-Marchal, Alexandra and Legros, Vincent and Leroy, Eric M},
  title = {A Large‐Scale Serological Survey in Pets From October 2020 Through June 2021 in France Shows Significantly Higher Exposure to SARS ‐ CoV ‐2 in Cats Compared to Dogs},
  journal = {Zoonoses and Public Health},
  year = {2025},
  doi = {10.1111/zph.13198}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche